Filing Details
- Accession Number:
- 0001209191-18-034209
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-05-30 17:32:31
- Reporting Period:
- 2018-05-30
- Accepted Time:
- 2018-05-30 17:32:31
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1659323 | Iterum Therapeutics Plc | ITRM | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1245624 | James Healy | C/O Iterum Therapeutics Limited, Blk 2 Fl. 3, Harcourt Centre, Harcourt St. Dublin L2 2 | Yes | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Acquisiton | 2018-05-30 | 721,408 | $0.00 | 721,408 | No | 4 | C | Indirect | By Sofinnova Venture Partners IX, L.P. |
| Ordinary Shares | Acquisiton | 2018-05-30 | 275,446 | $0.00 | 996,854 | No | 4 | C | Indirect | By Sofinnova Venture Partners IX, L.P. |
| Ordinary Shares | Acquisiton | 2018-05-30 | 229,660 | $0.00 | 1,226,514 | No | 4 | C | Indirect | By Sofinnova Venture Partners IX, L.P. |
| Ordinary Shares | Acquisiton | 2018-05-30 | 500,000 | $13.00 | 1,726,514 | No | 4 | P | Indirect | By Sofinnova Venture Partners IX, L.P. |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | C | Indirect | By Sofinnova Venture Partners IX, L.P. |
| No | 4 | C | Indirect | By Sofinnova Venture Partners IX, L.P. |
| No | 4 | C | Indirect | By Sofinnova Venture Partners IX, L.P. |
| No | 4 | P | Indirect | By Sofinnova Venture Partners IX, L.P. |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Ordinary Shares | Series A Preferred Shares | Disposition | 2018-05-30 | 721,408 | $0.00 | 721,408 | $0.00 |
| Ordinary Shares | Series B-1 Preferred Shares | Disposition | 2018-05-30 | 275,446 | $0.00 | 275,446 | $0.00 |
| Ordinary Shares | Series B-2 Preferred Shares | Disposition | 2018-05-30 | 229,660 | $0.00 | 229,660 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | C | Indirect | ||
| 0 | No | 4 | C | Indirect | ||
| 0 | No | 4 | C | Indirect |
Footnotes
- The Series A Preferred Shares automatically converted into Ordinary Shares of the Issuer on a 1-to-1 basis upon closing of the initial public offering of the Issuer.
- These shares are held directly by Sofinnova Venture Partners IX, L.P. (the "Fund"). The general partner of the Fund is Sofinnova Management IX, L.L.C. (the "GP") and may be deemed to have sole voting, investment and dispositive power with respect to the shares held by the Fund. Dr. James I. Healy, Michael F. Powell, Ph.D., and Dr. Anand Mehra are the managing members of the GP and may be deemed to have shared voting, investment and dispositive power with respect to the shares held by the Fund. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of his proportionate pecuniary interest therein, if any.
- The Series B-1 Preferred Shares automatically converted into Ordinary Shares of the Issuer on a 1-to-1 basis upon closing of the initial public offering of the Issuer.
- The Series B-2 Preferred Shares automatically converted into Ordinary Shares of the Issuer on a 1-to-1 basis upon closing of the initial public offering of the Issuer.
- Not applicable.
Billionaire Hedge Funds
